Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-25-002979
Filing Date
2025-04-25
Accepted
2025-04-25 16:01:17
Documents
1
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 7701
  Complete submission text file 0001477932-25-002979.txt   9197
Mailing Address 1165 WRACK ROAD MEADOWBROOK PA 19046
Business Address
Salkind Gene (Reporting) CIK: 0001592481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40535 | Film No.: 25873640

Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Issuer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)